Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models

Immune checkpoint blockade (ICB) is currently evaluated in patients with glioblastoma (GBM), based on encouraging clinical data in other cancers, and results from studies with the methylcholanthrene-induced GL261 mouse glioma. In this paper, we describe a novel model faithfully recapitulating some k...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Genoud, Vassilis, Marinari, Eliana, Nikolaev, Sergey I, Castle, John C., Bukur, Valesca, Dietrich, Pierre-Yves, Okada, Hideho, Walker, Paul R.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6279422/
https://ncbi.nlm.nih.gov/pubmed/30524896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1501137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados